Harnessing advances in structural MRI to enhance research on Parkinson's disease

Imaging in Medicine

Volumn 5, Issue 2, 2013, Pages 91-94

  Ziegler, David A ^a   Augustinack, Jean C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

basal forebrain; ex vivo MRI; multispectral MRI; Parkinson's disease; substantia nigra

Indexed keywords

BASAL GANGLION; BRAIN MAPPING; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; EX VIVO STUDY; FOREBRAIN; GOLD STANDARD; HUMAN; LOCUS CERULEUS; MAGNETIZATION PREPARED GRADIENT ECHO; MEDICAL RESEARCH; MORPHOMETRICS; MULTIECHO FAST LOW ANGLE SHOT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHIATRY; RADIODIAGNOSIS; RAPHE NUCLEUS; REVIEW; SLEEP DISORDER; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA;

EID: 84875721153     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.13.8     Document Type: Review

References (23)

1. Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu. Rev. Pathol. 6, 193-222 (2011).
2. Lim SY, Fox SH, Lang AE. Overview of the extranigral aspects of Parkinson disease. Arch. Neurol. 66(2), 167-172 (2009).
3. Godau J, Hussl A, Lolekha P, Stoessl AJ, Seppi K. Neuroimaging: current role in detecting pre-motor Parkinson's disease. Mov. Disord. 27(5), 634-643 (2012).
4. Marek K, Jennings D. Can we image premotor Parkinson disease? Neurology 72(Suppl. 7), S21-S26 (2009).
5. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J. Neurol. 253(1), 26-32 (2006).
6. Peran P, Cherubini A, Assogna F et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 133(11), 3423-3433 (2010).
7. Hutchinson M, Raff U, Lebedev S. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20(3), 1899-1902 (2003).
8. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am. J. Neuroradiol. 23(10), 1747-1756 (2002).
9. Oikawa H, Sasaki M, Ehara S, Abe T. Substantia innominata: MR findings in Parkinson's disease. Neuroradiology 46(10), 817-821 (2004).
10. Ziegler DA, Wonderlick JS, Ashourian P et al. Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease. JAMA Neurol. 70(2), 241-247 (2013).
11. Herbert MR, Ziegler DA. Volumetric neuroimaging and low-dose early-life exposures: loose coupling of pathogenesis-brain-behavior links. Neurotoxicology 26(4), 565-572 (2005).
12. Ziegler DA, Piguet O, Salat DH, Prince K, Connally E, Corkin S. Cognition in healthy aging is related to regional white matter integrity, but not cortical thickness. Neurobiol. Aging 31(11), 1912-1926 (2010).
13. Lichy MP, Wietek BM, Mugler JP 3rd et al. Magnetic resonance imaging of the body trunk using a single-slab, 3-dimensional, T2- weighted turbo-spin-echo sequence with high sampling efficiency (SPACE) for high spatial resolution imaging: initial clinical experiences. Invest. Radiol. 40(12), 754-760 (2005).
14. Fischl B, Salat DH, van der Kouwe AJ et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage 23(Suppl. 1), S69-S84 (2004).
15. van der Kouwe AJ, Benner T, Salat DH, Fischl B. Brain morphometry with multiecho MPRAGE. Neuroimage 40(2), 559-569 (2008).
16. Wonderlick JS, Ziegler DA, Hosseini-Varnamkhasti P et al. Reliability of MRI-derived cortical and subcortical morphometric measures: effects of pulse sequence, voxel geometry, and parallel imaging. Neuroimage 44(4), 1324-1333 (2009).
17. Augustinack JC, van der Kouwe AJ, Blackwell ML et al. Detection of entorhinal layer II using 7Tesla [corrected] magnetic resonance imaging. Ann. Neurol. 57(4), 489-494 (2005).
18. Eickhoff S, Walters NB, Schleicher A et al. High-resolution MRI reflects myeloarchitecture and cytoarchitecture of human cerebral cortex. Hum. Brain Mapp. 24(3), 206-215 (2005).
19. Augustinack JC, Huber KE, Stevens AA et al. Predicting the location of human perirhinal cortex, Brodmann's area 35, from MRI. Neuroimage 64, 32-42 (2013).
20. Fischl B, Stevens AA, Rajendran N et al. Predicting the location of entorhinal cortex from MRI. Neuroimage 47(1), 8-17 (2009).
21. Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 72(12), 1048-1055 (2009).
22. Dickerson BC, Bakkour A, Salat DH et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 19(3), 497-510 (2009).
23. Kantarci K, Ferman T J, Boeve BF et al. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 79(6), 553-560 (2012).